BIO-key International (NASDAQ:BKYI) Stock Passes Below Two Hundred Day Moving Average – What’s Next?

BIO-key International, Inc. (NASDAQ:BKYIGet Free Report)’s stock price crossed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $1.12 and traded as low as $0.71. BIO-key International shares last traded at $0.72, with a volume of 54,827 shares changing hands.

BIO-key International Stock Up 1.2 %

The company has a market capitalization of $2.28 million, a price-to-earnings ratio of -0.33 and a beta of 0.49. The firm’s 50-day simple moving average is $1.11 and its 200-day simple moving average is $1.11. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.71 and a current ratio of 0.78.

BIO-key International (NASDAQ:BKYIGet Free Report) last issued its earnings results on Thursday, March 27th. The technology company reported ($0.53) EPS for the quarter, missing the consensus estimate of ($0.35) by ($0.18). BIO-key International had a negative net margin of 72.53% and a negative return on equity of 3,124.77%. The firm had revenue of $1.46 million during the quarter, compared to analyst estimates of $2.29 million.

About BIO-key International

(Get Free Report)

BIO-key International, Inc develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform.

See Also

Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.